Raise or Fuld?

Uncovering another dire quarter, with $5.6 billion in net writedowns and a worse-than-expected $3.93 billion loss, Lehman Brothers said it plans to sell a majority stake in its investment management division and spin off commercial real estate assets. The Koreans aren’t buying — they officially ran for the hills overnight — and Lehman also moved […]

Blackstone - please pull your punches

Buyout firms get a bad rap and there isn’t enough perception of the good that the private equity industry does, said Blackstone Chief Operating Officer Tony James on Tuesday.
“We had the dubious distinction of being like a public punching bag for a year — by politicians, by press, by just about everyone,” James said at […]

Take two aspirin…

With the clock ticking down on its Lipitor patent, Pfizer is under pressure for the next big thing. With that in mind, talk that German drugs and chemicals group Bayer could be in its sights is not hard to swallow. Shares of Bayer, a $57 billion company, rose nearly 4 percent on the talk. It […]

CIT backtracks on rail

After months of trying to sell its rail leasing business, CIT pulled the plug on the auction, saying it no longer needed to do so.
CIT decided to keep its $4.5 billion rail franchise as a result of the progress it had made managing its balance sheet and strengthening its liquidity position, it said. 
“We are very […]

Raise or Fuld?

Uncovering another dire quarter, with $5.6 billion in net writedowns and a worse-than-expected $3.93 billion loss, Lehman Brothers said it plans to sell a majority stake in its investment management division and spin off commercial real estate assets. The Koreans aren’t buying — they officially ran for the hills overnight — and Lehman also moved […]

Blackstone - please pull your punches

Buyout firms get a bad rap and there isn’t enough perception of the good that the private equity industry does, said Blackstone Chief Operating Officer Tony James on Tuesday.
“We had the dubious distinction of being like a public punching bag for a year — by politicians, by press, by just about everyone,” James said at […]

Take two aspirin…

With the clock ticking down on its Lipitor patent, Pfizer is under pressure for the next big thing. With that in mind, talk that German drugs and chemicals group Bayer could be in its sights is not hard to swallow. Shares of Bayer, a $57 billion company, rose nearly 4 percent on the talk. It […]

CIT backtracks on rail

After months of trying to sell its rail leasing business, CIT pulled the plug on the auction, saying it no longer needed to do so.
CIT decided to keep its $4.5 billion rail franchise as a result of the progress it had made managing its balance sheet and strengthening its liquidity position, it said. 
“We are very […]